Literature DB >> 21666822

Resolving the negative data publication dilemma in translational stroke research.

Paul A Lapchak1, John H Zhang.   

Abstract

Entities:  

Year:  2011        PMID： 21666822      PMCID： PMC3109983          DOI： 10.1007/s12975-010-0057-x

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN： 1868-4483            Impact factor:   6.829


× No keyword cloud information.
  42 in total

Review 1.  Taking a light approach to treating acute ischemic stroke patients: transcranial near-infrared laser therapy translational science.

Authors:  Paul A Lapchak
Journal:  Ann Med       Date:  2010-11-01       Impact factor: 4.709

2.  Negative results and impact factor: a lesson from neonatology.

Authors:  Yoav Littner; Francis B Mimouni; Shaul Dollberg; Dror Mandel
Journal:  Arch Pediatr Adolesc Med       Date:  2005-11

Review 3.  The science of stroke: mechanisms in search of treatments.

Authors:  Michael A Moskowitz; Eng H Lo; Costantino Iadecola
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

4.  Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators.

Authors:  P Lyden; M Lu; C Jackson; J Marler; R Kothari; T Brott; J Zivin
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

5.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

6.  Stroke location and brain function in an embolic rabbit stroke model.

Authors:  Aliza T Brown; Robert D Skinner; Rene Flores; Leah Hennings; Michael J Borrelli; John Lowery; William C Culp
Journal:  J Vasc Interv Radiol       Date:  2010-04-22       Impact factor: 3.464

7.  Do current animal models of intracerebral hemorrhage mirror the human pathology?

Authors:  Opeolu Adeoye; Joseph F Clark; Pooja Khatri; Kenneth R Wagner; Mario Zuccarello; Gail J Pyne-Geithman
Journal:  Transl Stroke Res       Date:  2010-08-10       Impact factor: 6.829

8.  Effectiveness and safety of transcranial laser therapy for acute ischemic stroke.

Authors:  Justin A Zivin; Gregory W Albers; Natan Bornstein; Thomas Chippendale; Bjorn Dahlof; Thomas Devlin; Marc Fisher; Werner Hacke; William Holt; Sanja Ilic; Scott Kasner; Robert Lew; Marshall Nash; Julio Perez; Marilyn Rymer; Peter Schellinger; Dietmar Schneider; Stefan Schwab; Roland Veltkamp; Michael Walker; Jackson Streeter
Journal:  Stroke       Date:  2009-02-20       Impact factor: 7.914

9.  Effects of NXY-059 in experimental stroke: an individual animal meta-analysis.

Authors:  P M W Bath; L J Gray; A J G Bath; A Buchan; T Miyata; A R Green
Journal:  Br J Pharmacol       Date:  2009-04-27       Impact factor: 8.739

10.  NXY-059 for acute ischemic stroke.

Authors:  Kennedy R Lees; Justin A Zivin; Tim Ashwood; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; James Grotta; Patrick Lyden; Ashfaq Shuaib; Hans-Göran Hårdemark; Warren W Wasiewski
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245
View more
  10 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

2.  De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.

Authors:  Paul A Lapchak; David R Schubert; Pamela A Maher
Journal:  Transl Stroke Res       Date:  2011-06       Impact factor: 6.829

3.  Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors:  Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal:  Transl Stroke Res       Date:  2017-04-12       Impact factor: 6.829

4.  Translational Stroke Research Opportunities and a Strategy to Develop Effective Cytoprotection.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2017-03-08       Impact factor: 6.829

5.  A blinded, randomized study of L-arginine in small clot embolized rabbits.

Authors:  Paul A Lapchak; Jessica T Daley; Paul D Boitano
Journal:  Exp Neurol       Date:  2015-02-20       Impact factor: 5.330

6.  Bipyridine, an iron chelator, does not lessen intracerebral iron-induced damage or improve outcome after intracerebral hemorrhagic stroke in rats.

Authors:  Jayalakshmi Caliaperumal; Shannon Wowk; Sarah Jones; Yonglie Ma; Frederick Colbourne
Journal:  Transl Stroke Res       Date:  2013-08-06       Impact factor: 6.829

7.  Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

8.  An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke.

Authors:  Pitchaiah Mandava; Shreyansh D Shah; Anand K Sarma; Thomas A Kent
Journal:  Transl Stroke Res       Date:  2015-09-19       Impact factor: 6.829

9.  Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-06       Impact factor: 6.829

10.  Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke.

Authors:  Paul A Lapchak; Paul D Boitano
Journal:  J Neurol Neurophysiol       Date:  2014-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.